New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

New clinical trial to assess safety and efficacy of convalescent plasma to prevent COVID-19

There is only one approved, specific treatment for COVID-19, the illness caused by the novel coronavirus SARS-CoV-2, albeit with modest efficacy.